Investment Team

• Rolf Christof Dienst
• Rainer Strohmenger
• Regina Hodits
• Erich Schlick
• Thomas Widmann
• Lukas Guenther
• Venture Partners »
• Operations Team »

Portfolio

• Implanet
• invendo medical
• Oxford Immunotec
• Quanta
• Sovicell

Rainer Strohmenger General Partner

Contact Rainer

Assistant
Doris Gowik

About Rainer
With over 20 investments in start-up companies, Rainer is one of Europe’s most experienced venture capitalists in Life Sciences. Joining Wellington Partners in 1997, he became a Partner in December 2000. His fourteen years of investment activity have involved financing of some of the most successful European biotech, medtech, and diagnostics companies.

In the late 1990s he co-managed Wellington’s investment in Swiss biotech player Actelion, today a listed company with a market cap of more than four billion euros. He was also responsible for the investments in Grandis (acquired by Novartis), NoemaLife (Borsa Italiana:NOE), Wavelight (acquired by Alcon), immatics as well as mtm laboratories (acquired by Roche).

Prior to joining Wellington Partners, Rainer was involved in medical research with a primary focus on cardiovascular physiology and in research on health economics at the Ludwig-Maximilians University in Munich.

Rainer studied medicine and economics and holds a doctorate in medicine as well as a master's degree in economics.